WIGRETTES Drug Patent Profile
✉ Email this page to a colleague
When do Wigrettes patents expire, and when can generic versions of Wigrettes launch?
Wigrettes is a drug marketed by Organon Usa Inc and is included in one NDA.
The generic ingredient in WIGRETTES is ergotamine tartrate. There are thirteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ergotamine tartrate profile page.
Summary for WIGRETTES
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 21 |
| Patent Applications: | 7 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | WIGRETTES at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for WIGRETTES
US Patents and Regulatory Information for WIGRETTES
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Organon Usa Inc | WIGRETTES | ergotamine tartrate | TABLET;SUBLINGUAL | 086750-001 | Jul 29, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
